3PARSONS SL, WATSON SA, BROWN PD, et al. Matrix metalloproteinases [J]. Br J Surg, 1997, 84 (2):160- 166.
4BAKER AH, ZALTSMAN AB, GEORGE SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase - 1,- 2, or - 3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro, TIMP - 3 promotes apoptosis [J]. J Clin Invest, 1998, 101 (6):1478- 1487.
5GREENE J, WANG M, LIU YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase- 4 [J]. J Biol Chem, 1996, 271(48) : 30375 - 30380.
6STEINMANN - NIGGLI K, ZTSWILER R, KUNG M,et al. Inhibition of matrix metalloproteinases attenuates anti- Thy1. 1 nephritis [J ]. J Am Soc Nephrol,1998, 9 (3): 397-407.
7COSSINS J, DUDGEON TJ, CATLIN G, et al. Identification of MMP - 18, a putative novel human matrix metalloproteinase [ J ]. Biochem Biophys Res Commun,1996, 228 (2): 494-498.
8LI L, AKERS K, EISEN AZ, et al. Activation of gelatinase A (72- KDa type Ⅳ collagenase ) induced by monensin in normal human fibroblasts [ J ]. Exp Cell Res, 1997, 232 (2): 322- 330.
9RIES C, PETRIDES PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease [J ]. Biol Chem Hoppe Seyler, 1995, 376(6): 345 - 355.
10AKIYAMA K, SHIKATA K, SUGIMOTO H, et al.Changes in serum concentrations of matrix metalloproteinases, tissue inhibitor of metalloproteinases and type Ⅳ collagen in patients with various types of glomerulonephritis [J]. Res Commun Mol Pathol Pharmacol, 1997,95 (2): 115-128.
